ID: ALA2335931

Max Phase: Preclinical

Molecular Formula: C8H12N8

Molecular Weight: 220.24

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCn1cnc2c(NC(=N)N)nc(N)nc21

Standard InChI:  InChI=1S/C8H12N8/c1-2-16-3-12-4-5(13-7(9)10)14-8(11)15-6(4)16/h3H,2H2,1H3,(H6,9,10,11,13,14,15)

Standard InChI Key:  QWMHGUQVUMPWQV-UHFFFAOYSA-N

Associated Targets(Human)

MCF7 126967 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cyclin-dependent kinase 2/cyclin E1 1877 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cyclin-dependent kinase 1/cyclin B1 1887 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Aurora kinase A/B 33 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 220.24Molecular Weight (Monoisotopic): 220.1185AlogP: -0.27#Rotatable Bonds: 2
Polar Surface Area: 131.52Molecular Species: NEUTRALHBA: 6HBD: 4
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 8.11CX LogP: -0.30CX LogD: -1.08
Aromatic Rings: 2Heavy Atoms: 16QED Weighted: 0.41Np Likeness Score: -0.84

References

1. Dolečková I, Cesnek M, Dračinský M, Brynda J, Voller J, Janeba Z, Kryštof V..  (2013)  Synthesis and biological evaluation of guanidino analogues of roscovitine.,  62  [PMID:23399722] [10.1016/j.ejmech.2013.01.021]

Source